We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Current understanding of human microbiome
- Diet, microbiome and host energy balance
- Microbiome dysbiosis and health disorders
- Heterogeneity in treatment outcomes
- Different individuals respond to drugs differently
- Individual variability in drug response (IVDR)
- Pharmacokinetics (PK) vs. pharmacodynamics (PD)
- Pharmacokinetics of orally administered drugs
- Pharmacokinetics of orally administered drugs - microbial load
- Host and microbial functions that modulate drug metabolism
- Untangle host and microbial contributions to drug metabolism
- Bidirectional interactions between microbes and drug metabolism
- Metabolism of drugs that target microbes
- Metabolism of non-antibiotic drugs
- Pharmacokinetics of anticancer drugs
- Gut microbiome modulation & cancer immunotherapy
- Gut microbiome, dietary metabolism & heart failure
- Pharmacokinetics of cardiac glycosides
- Complex pathophysiology of obesity and T2D
- Pharmacological approaches used to control hyperglycaemia in T2D
- Pharmacokinetics and pharmacodynamics pathways of metformin
- Endogenous GLP-1 and its pharmacodynamics
- Gut microbiota metabolites and brain physiology
- Pharmacokinetics of levodopa
- Conclusion
- Disclosure
- Funding acknowledgements
- Team members
- Thanks for your attention
Topics Covered
- Diet, microbiome and host energy balance
- Heterogeneity in treatment outcomes
- Pharmacokinetics of orally administered drugs
- Interactions between microbes and drug metabolism
- Gut microbiome modulation and cancer immunotherapy
- Gut microbiota metabolites and brain physiology
Links
Categories:
Therapeutic Areas:
Talk Citation
Das, B. (2025, July 31). Microbiome in drug metabolism and pharmacodynamics [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved August 23, 2025, from https://doi.org/10.69645/AEFS8748.Export Citation (RIS)
Publication History
- Published on July 31, 2025
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Vaccines
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Bhabatosh Das,
and I am a professor at the
Translational Health Science
and Technology
Institute in India.
My research focuses on
the human microbiome,
exploring its
composition, diversity,
and function in both
health and disease.
Specifically, I'm interested in
how the microbiome
influences host physiology,
drug metabolism, and
treatment outcomes.
Today, I will discuss
about the human microbiome
and its significant role
in drug metabolism.
We'll explore how these
insights can enhance
our understanding of
therapeutic strategy
and ultimately
improve human health.
0:45
The human microbiome is
a complex ecosystem of
trillions of
microorganisms residing in
almost all environmentally
exposed surfaces of the body.
But the microbial load
depends on the body size.
You can see that
the highest number
of microbes reside
in the human colon
and the minimum number of
microbes reside in
the gastric juice.
Not only the microbial loads,
but also, if you
look at the types of
microbes that reside in
each of these body sites,
they are also very distinct.
For example, if we look at
the reproductive
tract microbiome
of reproductive age women,
then you'll find that most
of the lactobacillus species
dominate this environment.
For example, it's
Lactobacillus crispatus,
Lactobacillus gasseri,
jensenii, johnsonii.
When we look at the microbiome
that resides in the colon,
it is mostly dominated by
the Prevotella, Bacteroides,
and Faecalibacterium.
The load of microbes varies
in different body sites,
and some things in their
functionality also vary.
If you look at genomic potency,
the number of genes
carried by these microbes
is approximately 30 times more
than the genes encoded
by our own genome.
That literally means
the microbes contribute
to human physiology
and play an important role
in almost each and every
aspect of the activities
that we do regularly.
Now, what are the
factors that actually
modulate the composition and
functions of the microbiome?
If we say gut, it's
definitely the diet.